Non-opioid nociceptive activity of human dynorphin mutants that cause neurodegenerative disorder spinocerebellar ataxia type 23

Peptides

Volumn 35, Issue 2, 2012, Pages 306-310

  Watanabe, Hiroyuki ^a   Mizoguchi, Hirokazu ^b   Verbeek, Dineke S ^c   Kuzmin, Alexander ^a,d   Nyberg, Fred ^a   Krishtal, Oleg ^e   Sakurada, Shinobu ^b   Bakalkin, Georgy ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Stockholms Läns Landstinget Enskede Årsta Vantör Socialpsykiatriska ^*  (Sweden)

^e BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

Dynorphin A mutant; Mice; Neurodegeneration; Nociception; Non opioid activity

Indexed keywords

DIZOCILPINE; DYNORPHIN A; MORPHINE; NALOXONE; NEUROKININ A; NUCLEIC ACID BINDING PROTEIN; PRODYNORPHIN; PROTEIN SCA23; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL RESEARCH; CONTROLLED STUDY; MALE; MISSENSE MUTATION; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

AMINO ACID SUBSTITUTION; ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DYNORPHINS; HUMANS; MALE; MICE; MICE, INBRED ICR; MORPHINE; MUTATION, MISSENSE; NALOXONE; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; RECEPTORS, TACHYKININ; SPINOCEREBELLAR DEGENERATIONS;

MUS;

EID: 84861193651     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.04.006     Document Type: Article

References (47)

1. L.M. Aanonsen, and G.L. Wilcox Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists J Pharmacol Exp Ther 243 1987 9 19 (Pubitemid 17162692)
2. U. Arvidsson, M. Riedl, S. Chakrabarti, L. Vulchanova, J.H. Lee, and A.H. Nakano The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids Proc Natl Acad Sci USA 92 1995 5062 5066
3. G. Bakalkin, H. Watanabe, J. Jezierska, C. Depoorter, C. Verschuuren-Bemelmans, and I. Bazov Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23 Am J Hum Genet 87 2010 593 603
4. Bazov I, Kononenko O, Watanabe H, Kuntic V, Sarkisyan D, Taqi MM, et al. The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction. Addict Biol, in press.
5. L.J. Botticelli, B.M. Cox, and A. Goldstein Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia Proc Natl Acad Sci USA 78 1981 7783 7786 (Pubitemid 12186647)
6. R.M. Caudle, and R. Dubner Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus Neuropeptides 32 1998 87 95 (Pubitemid 28167864)
7. R.I. Cone, E. Weber, J.D. Barchas, and A. Goldstein Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary J Neurosci 3 1983 2146 2152 (Pubitemid 14248172)
8. A. Durr Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond Lancet Neurol 9 2010 885 894
9. A.I. Faden Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury Ann Neurol 27 1990 67 74 (Pubitemid 20031360)
10. R. Gamse, and A. Saria Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice Neurosci Lett 70 1986 143 147 (Pubitemid 16023254)
11. L.R. Gardell, M. Ibrahim, R. Wang, Z. Wang, M.H. Ossipov, and T.P. Malan Jr. Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain Neuroscience 123 2004 43 52 (Pubitemid 37518474)
12. M. Gleichmann, and M.P. Mattson Neuronal calcium homeostasis and dysregulation Antioxid Redox Signal 14 2011 1261 1273
13. R.J. Goody, K.M. Martin, S.M. Goebel, and Hauser K.F. Dynorphin A toxicity in striatal neurons via an alpha-amino-3-hydroxy-5-methylisoxazole-4- propionate/kainate receptor mechanism Neuroscience 116 2003 807 816 (Pubitemid 36160575)
14. K.F. Hauser, J.V. Aldrich, K.J. Anderson, G. Bakalkin, M.J. Christie, and E.D. Hall Pathobiology of dynorphins in trauma and disease Front Biosci 10 2005 216 235 (Pubitemid 40543030)
15. J.P. Headrick, A.I. Faden, and R. Vink Intrathecal dynorphin-A infusion in rat spinal cord causes energy depletion, edema and neurologic dysfunction Neurochem Int 26 1995 489 495
16. V. Hollt Opioid peptide processing and receptor selectivity Annu Rev Pharmacol Toxicol 26 1986 59 77 (Pubitemid 16090954)
17. W.H. Hu, F.C. Lee, X.S. Wan, Y.T. Chen, and M.F. Jen Dynorphin neurotoxicity induced nitric oxide synthase expression in ventral horn cells of rat spinal cord Neurosci Lett 203 1996 13 16
18. L. Hugonin, V. Vukojevic, G. Bakalkin, and A. Graslund Calcium influx into phospholipid vesicles caused by dynorphin neuropeptides Biochim Biophys Acta 1778 2008 1267 1273
19. L. Hugonin, V. Vukojevic, G. Bakalkin, and A. Graslund Membrane leakage induced by dynorphins FEBS Lett 580 2006 3201 3205 (Pubitemid 43729662)
20. J.L. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur J Pharmacol 67 1980 313 316 (Pubitemid 10007057)
21. J.L. Hylden, and G.L. Wilcox Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice Brain Res 217 1981 212 215 (Pubitemid 11072722)
22. J.L. Hylden, and G.L. Wilcox Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level J Pharmacol Exp Ther 226 1983 398 404 (Pubitemid 13041514)
23. H. Itoh, T. Andoh, I. Watanabe, T. Sasaki, Y. Kamiya, and F. Okumura Dynorphins directly inhibit neuronal nicotinic acetylcholine receptors in PC12 cells Eur J Neurosci 12 2000 1253 1262 (Pubitemid 30224229)
24. A.T. Knoll, and W.A. Carlezon Jr. Dynorphin, stress, and depression Brain Res 1314 2010 56 73
25. M. Kolaj, R. Cerne, and M. Randic The opioid peptide dynorphin modulates AMPA and kainate responses in acutely isolated neurons from the dorsal horn Brain Res 671 1995 227 244
26. A. Kuzmin, N. Madjid, L. Terenius, S.O. Ogren, and G. Bakalkin Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice Neuropsychopharmacology 31 2006 1928 1937
27. J. Lai, M.C. Luo, Q. Chen, S. Ma, L.R. Gardell, and M.H. Ossipov Dynorphin A activates bradykinin receptors to maintain neuropathic pain Nat Neurosci 9 2006 1534 1540 (Pubitemid 44862662)
28. S.L. Lai, Y. Gu, and L.Y. Huang Dynorphin uses a non-opioid mechanism to potentiate N-methyl-d-aspartate currents in single rat periaqueductal gray neurons Neurosci Lett 247 1998 115 118 (Pubitemid 28240110)
29. T.M. Laughlin, A.A. Larson, and G.L. Wilcox Mechanisms of induction of persistent nociception by dynorphin J Pharmacol Exp Ther 299 2001 6 11 (Pubitemid 32905112)
30. J.B. Long, D.D. Rigamonti, B. de Costa, K.C. Rice, and A. Martinez-Arizala Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine Brain Res 497 1989 155 162 (Pubitemid 19219923)
31. F. Madani, M.M. Taqi, S.K. Warmlander, D.S. Verbeek, G. Bakalkin, and A. Graslund Perturbations of model membranes induced by pathogenic dynorphin A mutants causing neurodegeneration in human brain Biochem Biophys Res Commun 411 2011 111 114
32. Z. Marinova, V. Vukojevic, S. Surcheva, T. Yakovleva, G. Cebers, and N. Pasikova Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission J Biol Chem 280 2005 26360 26370 (Pubitemid 41022234)
33. T.K. McIntosh, S. Fernyak, I. Yamakami, and A.I. Faden Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats Am J Physiol 267 1994 R665 R672
34. J. Mika, I. Obara, and B. Przewlocka The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction Neuropeptides 45 2011 247 261
35. K. Oka, T. Andoh, I. Watanabe, Y. Kamiya, and H. Ito Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells Pflugers Arch 436 1998 887 893 (Pubitemid 28496735)
36. T. Sakurada, K. Tan-No, T. Yamada, S. Sakurada, K. Kisara, and M. Ohba N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice Life Sci 47 1990 PL109 PL113
37. C. Schwarzer 30 years of dynorphins - new insights on their functions in neuropsychiatric diseases Pharmacol Ther 123 2009 353 370
38. T.W. Sherwood, and C.C. Askwith Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death J Neurosci 29 2009 14371 14380
39. V.K. Shukla, J.A. Prasad, and S. Lemaire Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-d-aspartate receptor J Pharmacol Exp Ther 283 1997 604 610 (Pubitemid 27514616)
40. J. Silberring, and F. Nyberg A novel bovine spinal cord endoprotease with high specificity for dynorphin B J Biol Chem 264 1989 11082 11086 (Pubitemid 19168834)
41. T. Tachibana, K. Miki, T. Fukuoka, A. Arakawa, M. Taniguchi, and S. Maruo Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization J Neurotrauma 15 1998 485 494 (Pubitemid 28313407)
42. K. Takahasi, T. Sakurada, S. Sakurada, H. Kuwahara, A. Yonezawa, and R. Ando Behavioural characterization of substance P-induced nociceptive response in mice Neuropharmacology 26 1987 1289 1293 (Pubitemid 17158179)
43. K. Tan-No, A. Esashi, O. Nakagawasai, F. Niijima, T. Tadano, and C. Sakurada Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism Brain Res 952 2002 7 14 (Pubitemid 35279483)
44. K. Tan-No, H. Takahashi, O. Nakagawasai, F. Niijima, T. Sato, and S. Satoh Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation Pain 113 2005 301 309 (Pubitemid 40127511)
45. G. Urca, and G. Raigorodsky Behavioral classification of excitatory amino acid receptors in mouse spinal cord Eur J Pharmacol 153 1988 211 220
46. Z. Wang, L.R. Gardell, M.H. Ossipov, T.W. Vanderah, M.B. Brennan, and U. Hochgeschwender Pronociceptive actions of dynorphin maintain chronic neuropathic pain J Neurosci 21 2001 1779 1786 (Pubitemid 32182217)
47. S. Wee, and G.F. Koob The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse Psychopharmacology (Berl) 210 2010 121 135